Gates Foundation to fund research on antibiotic resistance
ASU Professor Banu Ozkan is working on a team of researchers who aim to find alternative pathways to address the urgent need for new antibiotics. Ozkan's contribution to the research project focuses on understanding the dynamics of ribosomes in dormant bacteria. Illustration courtesy Banu Ozkan
Antibiotic resistance, what happens when germs develop the ability to defeat the drugs designed to kill them, is a growing concern among scientists today.
When bacteria become resistant to antibiotics, common infections can be harder or impossible to treat, leading to longer illnesses, more severe infections or higher mortality rates.
Using a combination of theoretical and experimental techniques, Arizona State University Department of Physics Professor Banu Ozkan and a team of researchers have been working to find new ways to cope with bacterial infections.
The team, which includes Gürol Süel, the project’s principal investigator from the University of California San Diego, and Bozhi Tian from the University of Chicago, recently received a grant from the Bill & Melinda Gates Foundation to further their research.
“Understanding antibiotic resistance is a big problem now because it’s hard to come up with new antibiotics, and bacteria are getting smarter to current antibiotics,” said Ozkan, director of the Center for Biological Physics at ASU. “This research would help us create new and novel ways to control or kill bacteria as an alternative to antibiotics.”
When bacteria enter a dormant state, they are not actively reproducing. This helps them survive harsh conditions such as lack of nutrients, extreme temperature or antibiotic exposure.
After conditions become favorable again, bacteria wake up and resume normal activities of causing infections or spreading antibiotic resistance.
“A dormant state is interesting. They’re alive but have zero metabolism,” Ozkan said. “They can stay like that for a long time and then turn back and become alive again. We want to understand how bacteria go from a dormant to waking state.”
To do so, the researchers are developing miniature devices capable of delivering electric signals to bacteria to understand how bacteria exit dormant states and how they can be manipulated. This work may in the future reveal new ways to cope with bacterial infections.
Ozkan’s contribution to the research project focuses on understanding the dynamics of ribosomes in dormant bacteria.
Ribosomes, essential cellular machines responsible for making proteins, play a crucial role in regulating bacterial activity and are targets for many antibiotics.
“Ribosomes stick together, forming what we call 'ribosome hundreds,' halting protein translation. Understanding the dynamics of their association and dissociation, particularly with novel mechanisms like electric stimulation, is crucial,” Ozkan said.
The team hopes to find alternative pathways to address the urgent need for new antibiotics.
“This is a great opportunity. The different strengths of all three of us working together to address this issue wouldn’t happen without receiving funding for this research,” Ozkan said.
More Health and medicine
First 2 degree offerings from ASU Health available in fall 2025
The first degree offerings from ASU Health will help students find jobs in the modernized health care system.The one-year Master of Science in public health technology and the two-year Master of…
ASU study uses new biomaterials for wound healing
A minor cut often heals within days, vanishing without a trace. Yet, wound healing and tissue repair are complex biological processes, revealing the body’s remarkable regenerative capacity.In a new…
Moeur awardee seeks to turn passion into tangible human impact
Editor’s note: This story is part of a series of profiles of notable fall 2024 graduates.During high school, Nguyen Thien Ha Do, a graduating student in the medical studies program at the…